C&P Exam Prep Guide for Hepatitis C (DC 7354)

Read the C&P exam preparation guideWhat happens at the exam, what 38 CFR Part 4 requires the examiner to record, and what to bring.
Build your prep packet for this conditionOrganize the codes, your symptoms, records, and a body-map into one printable sheet. Private to your device.
Diagnostic code: 7354Condition: Hepatitis C (or non-A, non-B hepatitis)Regulation: 38 CFR § 4.114DBQ: GI Liver Conditions

YOUR EXAM BLUEPRINT

Hepatitis C

A liver-condition exam reviews your symptoms, history, and lab results. The rating depends on symptoms and episodes of worsening, under 38 CFR 4.114.

DC 7354

DBQ used for this condition

What the examination is likely to focus on

History and interviewFatigue, nausea, abdominal pain, jaundice (yellowing), or weight loss. Hepatitis or other liver disease, and any alcohol history. Episodes of worsening, hospitalizations, and current treatment.
Physical examinationAbdominal exam, checking the liver for enlargement or tenderness. Looking for jaundice, swelling, or other signs of liver disease.
Diagnostic testingLab tests and imaging the examiner reviews. Liver function tests, Hepatitis panel, Ultrasound or imaging, Biopsy.
Functional assessmentSymptoms such as fatigue, weight loss, and incapacitating episodes, and any liver damage, which set the rating. Findings map to the tiers in 38 CFR 4.114 (hepatitis C DC 7354; chronic liver disease DC 7345).

Functional-impact topics to describe

  • Symptoms such as fatigue, weight loss, and incapacitating episodes, and any liver damage, which set the rating.
  • Findings map to the tiers in 38 CFR 4.114 (hepatitis C DC 7354; chronic liver disease DC 7345).
This blueprint is preparation guidance, not a prediction of the examination or claim outcome.RateMyVSO.net

Which form the examiner uses

For hepatitis c (DC 7354), the C&P examiner completes the following Disability Benefits Questionnaire (DBQ):

DBQs are Department of Veterans Affairs Form 21-0960 series documents. Public DBQs are hosted on benefits.va.gov. A handful are examiner-only and are not posted publicly.

The DBQ topics for this condition

These are the parts of the DBQ form that apply to hepatitis C (or non-A, non-B hepatitis) (DC 7354). Sections the form uses for other conditions are left out. Topics marked Only if this applies depend on your own history, such as surgery, a device, or a complication; open one if it applies to you. Section and question numbers are the ones printed on the VA form.

Liver Conditions

Open the full VA form (PDF, reference copy) Updated on: 2024-07-05

Section I Diagnosis Form page 1

Printed at the top of this section (1)
  • Note: These are condition(s) for which an evaluation has been requested on the exam request form (Internal VA) or for which the Veteran has requested medical evidence be provided for submission to VA.
  1. 1A. List the claimed condition(s) that pertain to this questionnaire:
    • Note: These are the diagnoses determined during this current evaluation of the claimed condition(s) listed above. If there is no diagnosis, if the diagnosis is different from a previous diagnosis for this condition, or if there is a diagnosis of a complication due to the claimed condition(s), explain your findings and reasons in the Remarks section. Date of diagnosis can be the date of the evaluation if the clinician is making the initial diagnosis or an approximate date determined through record review or reported history.
  2. 1B. Does the Veteran have or has the Veteran ever had a liver condition?
    • (If yes, complete 1C)
  3. 1C. Select diagnoses associated with the claimed condition(s) (check all that apply)
    Options printed on the form (19)
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Autoimmune hepatitis
    • Drug induced hepatitis
    • Non-alcoholic steatohepatitis (NASH)
    • Cirrhosis of the liver
    • Primary sclerosing cholangitis
    • Primary biliary cirrhosis
    • Liver abscess
    • Liver transplant
    • Liver cancer
    • Hemochromatosis
    • Wilson's disease
    • Alpha-1 antitrypsin deficiency
    • Other liver conditions:
    • Other diagnosis #1
    • Other diagnosis #2
    • Other diagnosis #3
  4. 1D. If there are additional diagnoses that pertain to liver conditions, list using above format:
  5. 1E. Remarks:
    • Note: Determination of these conditions requires documentation by appropriate serologic testing, abnormal liver function tests, and/or abnormal liver biopsy or imaging tests. If test results are documented in the medical record, additional testing is not required.

Section II Medical History Form page 2

  1. 2A. Describe the history (including onset and course) of the Veteran's liver condition(s) (brief summary):

Section III Chronic Liver Disease Without Cirrhosis (including Hepatitis) Form page 3

Printed at the top of this section (2)
  • Note 1: Undernutrition: “Undernutrition” means a deficiency resulting from insufficient intake of one or multiple essential nutrients, or the inability of the body to absorb, utilize, or retain such nutrients. Undernutrition is characterized by failure of the body to maintain normal organ functions and healthy tissues. Signs and symptoms may include: Loss of subcutaneous tissue, edema, peripheral neuropathy, muscle wasting, weakness, abdominal distention, ascites, and Body Mass Index below normal range.
  • Note 2: Nutritional Support: The following describe various nutritional support methods used to treat certain digestive conditions. (1) Total parenteral nutrition or hyperalimentation is a special liquid mixture given into the blood through an intravenous catheter. The mixture contains proteins, carbohydrates (sugars), fats, vitamins, and minerals. Total parenteral nutrition bypasses the normal digestion in the stomach and bowel. (2) Assisted enteral nutrition requires a special liquid mixture (containing proteins, carbohydrates (sugar), fats, vitamins and minerals) to be delivered into the stomach or bowel through a flexible feeding tube. Percutaneous endoscopic gastrostomy is a type of assisted enteral nutrition in which a flexible feeding tube is inserted through the abdominal wall and into the stomach. Nasogastric or nasoenteral feeding tube is a type of assisted parental nutrition in which a flexible feeding tube is inserted through the nose into the stomach or bowel.
  1. 3A. Does the Veteran have or has the Veteran ever had signs or symptoms attributable to chronic or infectious liver disease?
    Options printed on the form (23)
    • If yes, check all that apply:
    • Previous history of liver disease
    • Asymptomatic
    • Fatigue
      If checked, indicate frequency:
    • Intermittent
    • Daily
    • Malaise
    • Anorexia
    • Hepatomegaly
    • Pruritus
    • Arthralgia
    • Causing weight loss
      If checked, provide baseline weight
    • and current weight
    • Baseline weight means the clinically documented average weight for the two-year period preceding the onset of illness or, if relevant, the weight recorded at the Veteran’s most recent discharge physical. If neither of these weights is available or currently relevant, then use ideal body weight as determined by either the Hamwi formula, or Body Mass Index tables, whichever is most favorable to the Veteran.
    • Substantial weight loss (involuntary loss greater than 20 percent of an individual’s baseline weight sustained for three months with diminished quality of self-care or work tasks)
    • Minor weight loss (involuntary weight loss between 10 and 20 percent of an individual’s baseline weight sustained for three months with gastrointestinal-related symptoms, involving diminished quality of self-care or work tasks, or decreased food intake)
    • Requiring continuous medication (other than parenteral antiviral therapy or parenteral immunomodulatory therapy)
      If checked, list medication: If checked, indicate date treatment started:
    • Date of completion of medication or anticipated date of completion:
    • Requiring parenteral antiviral therapy
      If checked, indicate date treatment started:
    • Date of completion of medication or anticipated date of completion:
    • Requiring parenteral immunomodulatory therapy
      If checked, indicate date treatment started:
    • Date of completion of medication or anticipated date of completion:
    • Other signs or symptoms, describe:
  2. 3B. Is treatment medically contraindicated for both parenteral antiviral therapy and parenteral immunomodulatory drugs? If yes, explain. For individuals for whom physicians recommend both parenteral antiviral therapy and parenteral immunomodulatory drugs, but for whom treatment is medically contraindicated, complete section IV.

Section IV Cirrhosis of the Liver Form page 4

Only if this applies: Cirrhosis is part of the diagnosis/residuals.
Printed at the top of this section (1)
  • Note: Biochemical studies, imaging studies, or biopsy must confirm liver dysfunction (including hyponatremia, thrombocytopenia, and/or coagulopathy).
  1. 4A. Does the Veteran have cirrhosis of the liver?
  2. 4B. Is treatment medically contraindicated for both parenteral antiviral therapy and parenteral immunomodulatory drugs?
    Options printed on the form (25)
    • If yes to either 4A or 4B, indicate signs and symptoms (check all that apply):
    • Asymptomatic but with a history of liver disease
    • Resolved following liver transplant
    • Weakness
    • Generalized weakness
    • Malaise
    • Daily fatigue
    • Anorexia
    • Abdominal pain
    • Continuous daily debilitating symptoms (describe in comments section)
    • Splenomegaly
    • Ascites (fluid in the abdomen)
    • Coagulopathy
    • Portal hypertension
    • Portal gastropathy (if checked, date(s) of episode(s) in past 24 months)
    • Date(s):
    • Hepatic encephalopathy (if checked, date(s) of episode(s) in past 24 months)
    • Date(s):
    • Hepatopulmonary syndrome
    • Hepatorenal syndrome
    • History of spontaneous bacterial peritonitis
    • Variceal hemorrhage (if checked, date(s) of episode(s) in past 24 months)
    • Date(s):
    • Other signs or symptoms, describe:
    • Comments
  3. 4C. Is there a MELD score available? If yes, please complete the following:
    • MELD Score:
    • Date:
    • Source:

Section V Liver Abscess Form page 5

Only if this applies: Liver abscess is present or has residuals.
  1. 5A. Does the Veteran have or has the Veteran ever had, a liver abscess caused by bacterial, viral, amebic, fungal or other agents?
    • If yes, what date was the abscess diagnosed?
    • Comments:
    • If date of initial diagnosis was 6 months or more in the past, also complete appropriate questionnaire(s) to address chronic residuals.

Section VI Liver Transplant Form page 5

Only if this applies: Transplant eligibility, awaiting transplant or completed transplant is part of this condition.
  1. 6A. Is the Veteran eligible for transplant surgery?
    • Comments:
    • Date medical evidence shows that a physician determined that the Veteran was eligible for transplant surgery:
  2. 6B. Is the Veteran awaiting transplant surgery?
    • Comments:
  3. 6C. Has the Veteran undergone transplant surgery?
    • Date(s) of transplant surgery:
    • Date(s) of hospital admission:
    • Date(s) of hospital discharge:
    • Current signs and symptoms:

Section VII Diagnostic Testing Form page 6

Printed at the top of this section (1)
  • Note: If this information is of record, repeat testing is not required. If testing has been performed and reflects Veteran's current condition, no further testing is required for this examination report.
  1. 7A. Have clinically relevant diagnostic imaging studies or other diagnostic procedures been performed or reviewed in conjunction with this examination?
    Options printed on the form (23)
    • If yes, check all that apply:
    • EUS (Endoscopic ultrasound)
    • Date:
    • Results:
    • ERCP (Endoscopic Retrograde Cholangiopancreatography)
    • Date:
    • Results:
    • Transhepatic cholangiogram
    • Date:
    • Results:
    • MRI or MRCP (Magnetic Resonance
    • Date:
    • Results:
    • Cholangiopancreatography)
    • Computed Tomography (CT)
    • Date:
    • Results:
    • Ultrasound
    • Date:
    • Results:
    • Other, describe:
    • Date:
    • Results:
  2. 7B. Have clinically relevant laboratory studies been performed or reviewed in conjunction with this examination?
    Options printed on the form (31)
    • If yes, check all that apply:
    • Recombinant immunoBlot assay (RIBA)
    • Date:
    • Results:
    • Hepatitis C genotype
    • Date:
    • Results:
    • Hepatitis C viral titers
    • Date:
    • Results:
    • AST
    • Date:
    • Results:
    • ALT
    • Date:
    • Results:
    • Alkaline phosphatase
    • Date:
    • Results:
    • Bilirubin
    • Date:
    • Results:
    • INR (PT)
    • Date:
    • Results:
    • Creatinine
    • Date:
    • Results:
    • Other, describe:
    • Date:
    • Results:
  3. 7C. Has a liver biopsy been performed?
    • Date of test:
    • Results:
  4. 7D. Are there any other clinically relevant diagnostic test findings and/or results related to the claimed condition(s) and/or diagnosis(es), that were reviewed in conjunction with this examination?
    • If yes, provide type of test or procedure, date and results (brief summary):
  5. 7E. If any test results are other than normal, indicate relationship of abnormal findings to diagnosed conditions:

Section VIII Tumors and Neoplasms Form page 7

Only if this applies: A related neoplasm or metastasis is present or was treated.
  1. 8A. Does the Veteran currently have, or has had, a benign or malignant neoplasm or metastases related to any condition in the diagnosis section?
    • If yes, complete this section:
  2. 8B. Is the neoplasm:
    • Benign
    • Malignant (if malignant select all that apply):
    • Active
    • In remission
    • Primary
    • Secondary (metastatic) (if secondary, indicate the primary site, if known):
  3. 8C. Has the Veteran completed treatment or is the Veteran currently undergoing treatment for a benign or malignant neoplasm or metastases?
    Options printed on the form (15)
    • No, watchful waiting
    • If yes, indicate type of treatment the Veteran is currently undergoing or has completed. Check all that apply:
    • Treatment completed
    • Surgery
      If checked, describe:
    • Date(s) of surgery:
    • Radiation therapy
    • Date of most recent treatment:
    • Date of completion of treatment or anticipated date of completion:
    • Antineoplastic chemotherapy
    • Date of most recent treatment:
    • Date of completion of treatment or anticipated date of completion:
    • Other therapeutic procedure
      If checked, describe procedure:
    • Date of most recent procedure:
    • Other therapeutic treatment
      If checked, describe treatment:
    • Date of completion of treatment or anticipated date of completion:
  4. 8D. Does the Veteran currently have any residuals or complications due to the neoplasm (including metastases) or its treatment, other than those already documented in the report above?
    • If yes, list residuals or complications (brief summary), and also complete the appropriate questionnaire:
  5. 8E. If there are additional benign or malignant neoplasms or metastases related to any of the diagnoses in the diagnosis section, describe using the above format:

Section IX Other Pertinent Physical Findings, Complications, Conditions, Signs, Symptoms, and Scars Form page 8

Only if this applies: Related additional findings, complications or scars are present.
  1. 9A. Does the Veteran have any other pertinent physical findings, complications, conditions, signs or symptoms related to the conditions listed in the diagnosis section above?
    • If yes, describe (brief summary):
  2. 9B. Does the Veteran have any scars or other disfigurement of the skin related to any conditions or to the treatment of any conditions listed in the diagnosis section?
    • If yes, complete appropriate dermatological questionnaire.
  3. 9C. Comments, if any:

Section X Functional Impact Form page 8

Printed at the top of this section (1)
  • Note: Provide the impact of only the diagnosed condition(s), without consideration of the impact of other medical conditions or factors, such as age.
  1. 10A. Regardless of the Veteran's current employment status, do the conditions listed in the diagnosis section impact his/her ability to perform any type of occupational task (such as standing, walking, lifting, sitting, etc.).
    • If yes, describe the functional impact of each condition, providing one or more examples:

Section XI Remarks Form page 9

Only if this applies: Additional relevant explanation, test context or examination limitations need to be recorded.
  1. 11A. Remarks (if any - please identify the section to which the remark pertains when appropriate):

1 other section of this form covers other conditions, the examiner's signature, or answers you gave above, and is not part of this prep view. The examiner still works from the whole form.

This is a preparation view built from the current public VA forms. It is not an official VA crosswalk, it does not decide which exam VA orders, and it does not tell the examiner to skip anything. Measurements, diagnoses and opinions on the form are the examiner's to record.

What to expect at your C&P exam

A liver-condition exam reviews your symptoms, history, and lab results. The rating depends on symptoms and episodes of worsening, under 38 CFR 4.114.

1Initial interview (history)

  • Fatigue, nausea, abdominal pain, jaundice (yellowing), or weight loss.
  • Hepatitis or other liver disease, and any alcohol history.
  • Episodes of worsening, hospitalizations, and current treatment.

2Physical examination

  • Abdominal exam, checking the liver for enlargement or tenderness.
  • Looking for jaundice, swelling, or other signs of liver disease.

3Diagnostic tests the examiner may rely on

Lab tests and imaging the examiner reviews.

Liver function tests what's this?
Blood tests that measure liver enzymes and proteins.
Hepatitis panel
Blood tests that check for hepatitis viruses.
Ultrasound or imaging what's this?
Pictures of the liver to check for scarring or growths.
A tissue sample examined to grade liver damage.

4Functional assessment

  • Symptoms such as fatigue, weight loss, and incapacitating episodes, and any liver damage, which set the rating.
  • Findings map to the tiers in 38 CFR 4.114 (hepatitis C DC 7354; chronic liver disease DC 7345).

Test explainers open MedlinePlus (NIH National Library of Medicine), or Wikipedia where MedlinePlus has no matching page. This describes what happens and what is measured, not how to influence a result.

Rating Levels for DC 7354

The following tiers are reproduced from 38 CFR Part 4, the VA Schedule for Rating Disabilities. Toggle between the official VA criteria and a Plain English explanation.

Plain-English summaries are AI-generated to explain the official criteria. The official 38 CFR language is the binding legal standard. When in doubt, ask a VSO.

Evidence cited in published BVA decisions for DC 7354

Each row counts the issues for this diagnostic code that the Board granted or denied and whose decision text discussed that type of evidence. An issue is one condition the Board ruled on, and one decision can contain several. Remanded issues are not included. This is a count from the public record, not a prediction or a recommendation for any claim.

  • Service treatment records: discussed in 4,884 granted or denied BVA issues (1,199 granted; 3,685 denied)
  • Buddy / lay statements: discussed in 2,961 granted or denied BVA issues (788 granted; 2,173 denied)
  • Medical literature: discussed in 492 granted or denied BVA issues (149 granted; 343 denied)

What the Board discussed in granted decisions for DC 7354

The themes below were extracted by clustering 500 grant-factor sentences from published Board of Veterans Appeals decisions for this diagnostic code. Frequencies indicate how often each theme appeared in the sample. This is a factual aggregate of the public record, not advice or strategy for any specific claim.

  1. 36% Benefit of the doubt doctrine explained or applied generally
    The Board cited the statutory benefit-of-the-doubt rule requiring resolution of approximate balance of positive and negative evidence in the claimant's favor, or noted its application or inapplicability to the claim at issue.
    181 of 500 sample sentences
  2. 20% Medical opinion found hepatitis C at least as likely as not service-related
    A VA examiner, private physician, or specialist opined that the veteran's hepatitis C was at least as likely as not incurred in or caused by active military service.
    98 of 500 sample sentences
  3. 15% Evidence in equipoise supporting hepatitis C service connection
    The Board found the evidence at least in relative equipoise on whether the veteran's hepatitis C was etiologically related to service, warranting a grant of service connection.
    74 of 500 sample sentences
  4. 11% In-service risk factors cited as nexus basis for hepatitis C
    The Board or examiner noted specific in-service risk factors—such as air gun inoculations, shared razors, tattoos, blood transfusions, needle sticks, or healthcare exposure—as the basis for a nexus opinion linking hepatitis C to service.
    55 of 500 sample sentences
  5. 8% Preponderance of evidence against claim; benefit of the doubt inapplicable
    The Board determined the preponderance of evidence weighed against the claim, making the benefit-of-the-doubt doctrine inapplicable and requiring denial.
    40 of 500 sample sentences
  6. 5% Examiner request for hepatitis C nexus opinion noted
    The Board or remand order directed an examiner to opine whether it was at least as likely as not that the veteran's hepatitis C had its onset during or was related to active service, including identified in-service risk factors.
    25 of 500 sample sentences
  7. 3% Secondary conditions linked to service-connected hepatitis C
    Medical opinions or Board findings documented that conditions such as cirrhosis, liver cancer, kidney disease, fatigue, arthritis, or depression were at least as likely as not proximately due to or aggravated by service-connected hepatitis C.
    15 of 500 sample sentences
  8. 2% Rating level determined under diagnostic code 7354
    The Board resolved the benefit of the doubt or weighed the evidence to assign or deny a specific disability rating percentage for service-connected hepatitis C under Diagnostic Code 7354.
    8 of 500 sample sentences
  9. 1% Negative or inadequate medical opinion noted in record
    The Board recorded an examiner's opinion that it was not at least as likely as not that the veteran's hepatitis C was service-related, or found a prior opinion speculative or otherwise inadequate.
    4 of 500 sample sentences

When the Board found the exam inadequate (DC 7354)

In 1,112 published Board of Veterans' Appeals decisions involving this condition, the Board found a C&P examination or medical opinion inadequate. Where the defect could be read from the decision, it was most often one of the following (counts are a floor from the decisions on file, not a total):

  1. 253 Failed to address a contention or part of the condition
  2. 245 Conclusion given without a supporting rationale
  3. 104 Veteran's lay statements not considered
  4. 70 Claims file or records not reviewed
  5. 59 Examiner said an opinion would require speculation
  6. 45 Opinion relied on the absence of records instead of the evidence
  7. 14 Exam too old to reflect current severity
  8. 12 Wrong legal standard or question applied
  9. 11 Flare-ups or functional loss not addressed

An inadequate exam is usually sent back for a new one rather than decided against the veteran. This is a factual report of published decisions, not advice about any exam or claim; whether an exam is adequate is decided case by case.

Disclaimer: This page reproduces public Department of Veterans Affairs forms (DBQs) and verbatim text from 38 CFR Part 4 (the VA Schedule for Rating Disabilities). It is informational only and is not legal or medical advice. For guidance on a specific claim, contact a VA-accredited representative.